These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9293618)

  • 21. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.
    Cawello W; Boekens H; Waitzinger J; Miller U
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):9-17. PubMed ID: 11837383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers.
    Chan KK; Buch A; Glazer RD; John VA; Barr WH
    Pharm Res; 1994 Mar; 11(3):432-7. PubMed ID: 8008712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of benazepril and pimobendan on serum angiotensin-converting enzyme activity in dogs.
    King JN; Christinaz C; Strehlau G; Hornfeld J
    J Vet Pharmacol Ther; 2018 Jun; 41(3):485-489. PubMed ID: 29392741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The absence of a pharmacokinetic interaction between aspirin and the angiotensin-converting enzyme inhibitor benazepril in healthy volunteers.
    Sioufi A; Pommier F; Gauducheau N; Godbillon J; Choi L; John V
    Biopharm Drug Dispos; 1994 Aug; 15(6):451-61. PubMed ID: 7993983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights on effect of kidney insufficiency on disposition of angiotensin-converting enzyme inhibitors: case of enalapril and benazepril in dogs.
    Toutain PL; Lefebvre HP; Laroute V
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1094-103. PubMed ID: 10688628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations.
    Kaiser G; Ackermann R; Sioufi A
    Am Heart J; 1989 Mar; 117(3):746-51. PubMed ID: 2919553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition of [14C]-benazepril hydrochloride in rat, dog and baboon. Absorption, distribution, kinetics, biotransformation and excretion.
    Waldmeier F; Schmid K
    Arzneimittelforschung; 1989 Jan; 39(1):62-7. PubMed ID: 2719745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive mechanism of action of the novel angiotensin converting enzyme inhibitor benazepril. Effect on isolated vascular preparations.
    Kuroda K; Fukuda Y; Nakao K; Inukai T
    Arzneimittelforschung; 1990 Sep; 40(9):968-73. PubMed ID: 2080946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.
    Macdonald NJ; Sioufi A; Howie CA; Wade JR; Elliott HL
    Br J Clin Pharmacol; 1993 Sep; 36(3):205-9. PubMed ID: 9114905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous determination of benazepril hydrochloride and benazeprilat in plasma by high-performance liquid chromatography/electrospray-mass spectrometry.
    Xiao W; Chen B; Yao S; Cheng Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):303-8. PubMed ID: 15639452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison in young and elderly subjects of the pharmacokinetics and pharmacodynamics of single and multiple doses of benazepril.
    Macdonald NJ; Elliott HL; Hughes DM; Reid JL
    Br J Clin Pharmacol; 1993 Sep; 36(3):201-4. PubMed ID: 9114904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steady-state pharmacokinetics and pharmacodynamics of benazeprilat in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats.
    LeRoy S; Berner B
    Pharm Res; 1991 Jul; 8(7):883-7. PubMed ID: 1924139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of benazepril, an angiotensin-converting enzyme inhibitor, as studied in conscious normotensive dogs.
    Ishibashi T; Tatebe S; Mitomi A; Tanaka M; Imai S
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):635-41. PubMed ID: 1652276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of different angiotensin converting enzyme inhibitors on coronary collateral circulation].
    Zhang XH; Ma XJ; Luo J; Shao JH; Geng QX; Zhu XL; Tang YS; Xu FY
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):592-5. PubMed ID: 15144597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a new benazepril hydrochloride chewable tablet and evaluation of its bioequivalence for treatment of heart failure in dogs.
    Qian M; Chen T; Zhou D; Zhang Z; Zhang Q; Tang S; Xiao X
    J Vet Pharmacol Ther; 2016 Feb; 39(1):98-101. PubMed ID: 26228576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection.
    Sioufi A; Pommier F; Kaiser G; Dubois JP
    J Chromatogr; 1988 Dec; 434(1):239-46. PubMed ID: 3243821
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
    Ames MK; Atkins CE; Lee S; Lantis AC; zumBrunnen JR
    Am J Vet Res; 2015 Dec; 76(12):1041-50. PubMed ID: 26618728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of the newer ACE inhibitors. A review.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1990 Sep; 19(3):177-96. PubMed ID: 2203579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.
    Balfour JA; Goa KL
    Drugs; 1991 Sep; 42(3):511-39. PubMed ID: 1720384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of the blood pressure response to exogenous angiotensin I after oral administration of benazepril to healthy adult horses.
    Afonso T; Giguère S; Rapoport G; Brown SA; Coleman AE
    Equine Vet J; 2017 May; 49(3):358-362. PubMed ID: 27224673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.